Rosenkranz Prize Winner Investigates Impact of Price Controls on Contraceptives
Natalia Serna, PhD, is this year’s Rosenkranz Prize for her research examining how price ceilings on oral contraceptives impact women’s health and their access to medicine in low- to middle-income countries, particularly those of Latin America.
QALY Ban Could Harm People with Disabilities and Chronic Illness
The U.S. House passed a bill that would ban the use of a metric known as quality-adjusted life-years (QALYs) in coverage and payment determinations for federal health-care programs. SHP's Joshua Salomon writes in this Health Affairs commentary the bill would compromise the evaluation of medical treatments.
In Conflict Zones and Borderlands, Paul Wise Protects the Health of Vulnerable Children
Stanford Health Policy's Paul Wise — professor of pediatrics and senior fellow at the Freeman Spogli Institute for International Studies — is featured in this Stanford Magazine story about his work at the U.S.-Mexico border as the federally appointed juvenile monitor and around the world as a pediatrician who works on behalf of children of conflict.
SHP's Keith Humphreys argues that California’s problem isn’t that it offers housing first to recovering addicts — which is desperately needed — but that it offers nothing else.
DREAMS Center for Diabetes Translational Research national enrichment program meeting draws early stage investigators focused on diabetes equity research.
The National Academies of Sciences, Engineering, and Medicine updates its 20-year-old report on inequities in the U.S. health-care system, with expert advise from Stanford Health Policy researchers.
Stanford Medicine researchers Jonathan Chen and Mary K. Goldstein are using data science and machine learning to help doctors make better informed decisions and health-care facilities to adopt a precision stewardship approach to combatting antimicrobial resistance.
In his new advisory on the public health crisis of firearm violence, U.S. Surgeon General Dr. Vivek Murthy cites research by Stanford Health Policy's Maya Rossin-Slater which lays out the devastating long-term impacts of school shootings on the classmates who survive them.
Paul Wise and Lauren Stoffel concede U.S. immigration policy has always experienced big ups and downs. What makes this moment unique, they write in this commentary, is that the contentious public sentiment is bearing down on an unprecedented number of unaccompanied children.
Rosenkranz Global Health Policy Research Symposium keynote speaker Mark Dybul talks about the great strides in international health systems over the last 25 years—but calls on next generation to disrupt a system that has become stagnant.
SHP's Michelle Mello and colleagues find that the most impactful court-imposed restrictions on health orders during the pandemic were in two key areas: orders that restricted religious activities, and actions taken by state and federal agencies.
This year's Rosenkranz Prize winner is Natalia Serna, PhD, a health economist investigating how women's health is impacted by price controls on oral contraceptives.
This new study by SHP's Adrienne Sabety examines the association between prescriber workforce exit, long-term opioid treatment discontinuation, and clinical outcomes.
The U.S. House passed a bill that would ban the use of a metric known as quality-adjusted life-years (QALYs) in coverage and payment determinations for federal health-care programs. SHP's Joshua Salomon writes in this Health Affairs commentary the bill would compromise the evaluation of medical treatments.
A new study led by Stanford Health Policy researchers finds that algorithmic changes to a chronic kidney disease care equation are likely insufficient to achieve health equity as many other structural inequities remain.
Stanford Health Policy's Paul Wise — professor of pediatrics and senior fellow at the Freeman Spogli Institute for International Studies — is featured in this Stanford Magazine story about his work at the U.S.-Mexico border as the federally appointed juvenile monitor and around the world as a pediatrician who works on behalf of children of conflict.
A team of Stanford researchers has determined that patients taking GLP-1 receptors used to lower blood glucose levels may not need to take a pause before surgery.
